GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Cash Flow Conversion Efficiency

Latest as of September 2023: 0.024x

Based on the latest financial reports, GlaxoSmithKline Pharmaceuticals Limited (GLAXO) has a cash flow conversion efficiency ratio of 0.024x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs362.20 Million ≈ $3.92 Million USD) by net assets (Rs15.40 Billion ≈ $166.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

GlaxoSmithKline Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how GlaxoSmithKline Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of GlaxoSmithKline Pharmaceuticals Limited for a breakdown of total debt and financial obligations.

GlaxoSmithKline Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of GlaxoSmithKline Pharmaceuticals Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
NorthWestern Corporation NASDAQ:NWE	0.019x
Mueller Water Products NYSE:MWA	0.060x
Shenzhen H&T Intelligent Control Co Ltd SHE:002402	0.049x
Shenzhen O-Film Tech Co Ltd SHE:002456	-0.025x
Gujarat Fluorochemicals Limited NSE:FLUOROCHEM	0.082x
Challenger Ltd AU:CGF	0.255x
E-L Financial Corp Ltd TO:ELF	0.019x
ENSTAR GROUP LTD DL-01 F:48R	N/A

Annual Cash Flow Conversion Efficiency for GlaxoSmithKline Pharmaceuticals Limited (2005–2025)

The table below shows the annual cash flow conversion efficiency of GlaxoSmithKline Pharmaceuticals Limited from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see market value of GlaxoSmithKline Pharmaceuticals Limited.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs19.51 Billion ≈ $211.03 Million	Rs12.90 Billion ≈ $139.50 Million	0.661x	+101.90%
2024-03-31	Rs17.78 Billion ≈ $192.24 Million	Rs5.82 Billion ≈ $62.94 Million	0.327x	+17.74%
2023-03-31	Rs17.41 Billion ≈ $188.31 Million	Rs4.84 Billion ≈ $52.37 Million	0.278x	-8.66%
2022-03-31	Rs26.63 Billion ≈ $287.99 Million	Rs8.11 Billion ≈ $87.68 Million	0.304x	-21.03%
2021-03-31	Rs14.99 Billion ≈ $162.12 Million	Rs5.78 Billion ≈ $62.50 Million	0.386x	+43.09%
2020-03-31	Rs18.21 Billion ≈ $196.89 Million	Rs4.90 Billion ≈ $53.05 Million	0.269x	+44.35%
2019-03-31	Rs21.40 Billion ≈ $231.41 Million	Rs3.99 Billion ≈ $43.19 Million	0.187x	-18.79%
2018-03-31	Rs20.57 Billion ≈ $222.49 Million	Rs4.73 Billion ≈ $51.13 Million	0.230x	+95.43%
2017-03-31	Rs20.07 Billion ≈ $217.03 Million	Rs2.36 Billion ≈ $25.52 Million	0.118x	+43.29%
2016-03-31	Rs16.96 Billion ≈ $183.42 Million	Rs1.39 Billion ≈ $15.05 Million	0.082x	-25.74%
2015-03-31	Rs24.44 Billion ≈ $264.32 Million	Rs2.70 Billion ≈ $29.21 Million	0.111x	-21.83%
2014-03-31	Rs19.90 Billion ≈ $215.18 Million	Rs2.81 Billion ≈ $30.42 Million	0.141x	-9.52%
2013-03-31	Rs20.07 Billion ≈ $217.03 Million	Rs3.14 Billion ≈ $33.91 Million	0.156x	-9.88%
2012-03-31	Rs19.36 Billion ≈ $209.34 Million	Rs3.36 Billion ≈ $36.30 Million	0.173x	-29.41%
2011-03-31	Rs19.52 Billion ≈ $211.06 Million	Rs4.79 Billion ≈ $51.84 Million	0.246x	-14.23%
2010-03-31	Rs17.86 Billion ≈ $193.16 Million	Rs5.12 Billion ≈ $55.32 Million	0.286x	+36.72%
2009-03-31	Rs15.76 Billion ≈ $170.39 Million	Rs3.30 Billion ≈ $35.69 Million	0.209x	-9.28%
2008-03-31	Rs13.81 Billion ≈ $149.33 Million	Rs3.19 Billion ≈ $34.48 Million	0.231x	+7.57%
2007-03-31	Rs12.05 Billion ≈ $130.29 Million	Rs2.59 Billion ≈ $27.97 Million	0.215x	-41.44%
2006-03-31	Rs9.53 Billion ≈ $103.08 Million	Rs3.49 Billion ≈ $37.78 Million	0.367x	+47.85%
2005-03-31	Rs9.24 Billion ≈ $99.90 Million	Rs2.29 Billion ≈ $24.77 Million	0.248x	--

About GlaxoSmithKline Pharmaceuticals Limited

NSE:GLAXO India Drug Manufacturers - General

Market Cap

$4.28 Billion

Rs395.80 Billion INR

Market Cap Rank

#3979 Global

#169 in India

Share Price

Rs2336.40

Change (1 day)

-1.28%

52-Week Range

Rs2259.50 - Rs3466.20

All Time High

Rs3466.20